Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma
Open Access
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 13 (4) , 1034-1049
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Is phosphoproteomics ready for clinical research?Clinica Chimica Acta, 2013
- Vimentin as a poor prognostic factor for triple-negative breast cancerJournal of Cancer Research and Clinical Oncology, 2013
- Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylationInternational Journal of Cancer, 2011
- Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease‐specific biomarkersProteomics, 2011
- Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surfaceJournal of Cellular Biochemistry, 2009
- Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomasBreast Cancer, 2008
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Human Plasma PeptideAtlasProteomics, 2005
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999
- Rapid identification of proteins by peptide-mass fingerprintingCurrent Biology, 1993